Identification of a novel human deoxynivalenol metabolite enhancing proliferation of intestinal and urinary bladder cells
暂无分享,去创建一个
G. Del Favero | R. Krska | G. Adam | R. Schuhmacher | B. Warth | Lydia Woelflingseder | Hannes Puntscher | D. Marko | B. Šarkanj | P. Fruhmann | G. Wiesenberger | Philipp Fruhmann
[1] S. De Henauw,et al. Human biomonitoring of multiple mycotoxins in the Belgian population: Results of the BIOMYCO study. , 2015, Environment international.
[2] F. Berthiller,et al. Metabolism of Deoxynivalenol and Deepoxy-Deoxynivalenol in Broiler Chickens, Pullets, Roosters and Turkeys , 2015, Toxins.
[3] M. Blaszkewicz,et al. Deoxynivalenol Exposure Assessment for Pregnant Women in Bangladesh , 2015, Toxins.
[4] M. Solfrizzo,et al. Biomonitoring of concurrent mycotoxin exposure among adults in Sweden through urinary multi-biomarker analysis. , 2015, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[5] R. Krska,et al. The Metabolic Fate of Deoxynivalenol and Its Acetylated Derivatives in a Wheat Suspension Culture: Identification and Detection of DON-15-O-Glucoside, 15-Acetyl-DON-3-O-Glucoside and 15-Acetyl-DON-3-Sulfate , 2015, Toxins.
[6] H. van Loveren,et al. Characterization of the modes of action of deoxynivalenol (DON) in the human Jurkat T-cell line , 2015, Journal of immunotoxicology.
[7] G. Font,et al. Preliminary Estimation of Deoxynivalenol Excretion through a 24 h Pilot Study , 2015, Toxins.
[8] G. Manda,et al. Dual Effects Exerted in Vitro by Micromolar Concentrations of Deoxynivalenol on Undifferentiated Caco-2 Cells , 2015, Toxins.
[9] R. Krska,et al. New tricks of an old enemy: isolates of F usarium graminearum produce a type A trichothecene mycotoxin , 2015, Environmental microbiology.
[10] A. Krnjic,et al. Overexpression of PAK1 Promotes Cell Survival in Inflammatory Bowel Diseases and Colitis-associated Cancer , 2015, Inflammatory bowel diseases.
[11] R. Krska,et al. Deoxynivalenol-sulfates: identification and quantification of novel conjugated (masked) mycotoxins in wheat , 2014, Analytical and Bioanalytical Chemistry.
[12] H. Humpf,et al. Determination of mycotoxin exposure in Germany using an LC-MS/MS multibiomarker approach. , 2014, Molecular nutrition & food research.
[13] S. Uhlig,et al. Fast and sensitive LC–MS/MS method measuring human mycotoxin exposure using biomarkers in urine , 2014, Archives of Toxicology.
[14] M. Das,et al. Deoxynivalenol induced mouse skin cell proliferation and inflammation via MAPK pathway. , 2014, Toxicology and applied pharmacology.
[15] R. Krska,et al. Sulfation of deoxynivalenol, its acetylated derivatives, and T2-toxin☆ , 2014, Tetrahedron.
[16] R. Krska,et al. In vitro glucuronidation kinetics of deoxynivalenol by human and animal microsomes and recombinant human UGT enzymes , 2014, Archives of Toxicology.
[17] A. Visconti,et al. Assessment of Multi-Mycotoxin Exposure in Southern Italy by Urinary Multi-Biomarker Determination , 2014, Toxins.
[18] Y. Tao,et al. Metabolism, distribution, and excretion of deoxynivalenol with combined techniques of radiotracing, high-performance liquid chromatography ion trap time-of-flight mass spectrometry, and online radiometric detection. , 2014, Journal of agricultural and food chemistry.
[19] R. Krska,et al. Urinary analysis reveals high deoxynivalenol exposure in pregnant women from Croatia. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[20] R. Krska,et al. Bio-monitoring of mycotoxin exposure in Cameroon using a urinary multi-biomarker approach. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[21] R. Krska,et al. New insights into the human metabolism of the Fusarium mycotoxins deoxynivalenol and zearalenone. , 2013, Toxicology letters.
[22] Rudolf Krska,et al. LC-MS/MS-based multibiomarker approaches for the assessment of human exposure to mycotoxins , 2013, Analytical and Bioanalytical Chemistry.
[23] M. Maresca. From the Gut to the Brain: Journey and Pathophysiological Effects of the Food-Associated Trichothecene Mycotoxin Deoxynivalenol , 2013, Toxins.
[24] D. Marko,et al. In vitro toxicity of amorphous silica nanoparticles in human colon carcinoma cells , 2012, Nanotoxicology.
[25] B. Šarkanj,et al. Urinary ochratoxin A and ochratoxin alpha in pregnant women. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[26] R. Krska,et al. Investigation of the hepatic glucuronidation pattern of the Fusarium mycotoxin deoxynivalenol in various species. , 2012, Chemical research in toxicology.
[27] R. Krska,et al. Development and validation of a rapid multi-biomarker liquid chromatography/tandem mass spectrometry method to assess human exposure to mycotoxins. , 2012, Rapid communications in mass spectrometry : RCM.
[28] R. Krska,et al. Assessment of human deoxynivalenol exposure using an LC-MS/MS based biomarker method. , 2012, Toxicology letters.
[29] R. Krska,et al. Synthesis of deoxynivalenol-3-ß-D-O-glucuronide for its use as biomarker for dietary deoxynivalenol exposure , 2012 .
[30] S. Cunha,et al. Development and validation of a gas chromatography-mass spectrometry method for determination of deoxynivalenol and its metabolites in human urine. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[31] Veronica M T Lattanzio,et al. Simultaneous LC–MS/MS determination of aflatoxin M1, ochratoxin A, deoxynivalenol, de-epoxydeoxynivalenol, α and β-zearalenols and fumonisin B1 in urine as a multi-biomarker method to assess exposure to mycotoxins , 2011, Analytical and bioanalytical chemistry.
[32] R. Krska,et al. Direct quantification of deoxynivalenol glucuronide in human urine as biomarker of exposure to the Fusarium mycotoxin deoxynivalenol , 2011, Analytical and bioanalytical chemistry.
[33] A. De Girolamo,et al. LC-MS/MS characterization of the urinary excretion profile of the mycotoxin deoxynivalenol in human and rat. , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[34] C. Wild,et al. Assessment of deoxynivalenol metabolite profiles in UK adults. , 2011, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[35] J. Pestka. Deoxynivalenol: mechanisms of action, human exposure, and toxicological relevance , 2010, Archives of Toxicology.
[36] C. Wild,et al. A comparison of deoxynivalenol intake and urinary deoxynivalenol in UK adults , 2010, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[37] J. Fisher,et al. Determinants of urinary deoxynivalenol and de-epoxy deoxynivalenol in male farmers from Normandy, France. , 2010, Journal of agricultural and food chemistry.
[38] J. Shay,et al. Immortalization of adult human colonic epithelial cells extracted from normal tissues obtained via colonoscopy , 2010 .
[39] C. Wild,et al. Urinary Deoxynivalenol Is Correlated with Cereal Intake in Individuals from the United Kingdom , 2007, Environmental health perspectives.
[40] Joint Fao,et al. Safety evaluation of certain contaminants in food , 2006 .
[41] C. Wild,et al. Development of a urinary biomarker of human exposure to deoxynivalenol. , 2003, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[42] Joint Fao,et al. Safety evaluation of certain mycotoxins in food , 2001 .
[43] H. Glatt,et al. Sulfotransferases: genetics and role in toxicology. , 2000, Toxicology letters.
[44] Toxins derived from Fusarium graminearum, F. culmorum and F. crookwellense: zearalenone, deoxynivalenol, nivalenol and fusarenone X. , 1993, IARC monographs on the evaluation of carcinogenic risks to humans.
[45] D. Scudiero,et al. New colorimetric cytotoxicity assay for anticancer-drug screening. , 1990, Journal of the National Cancer Institute.
[46] D. Veira,et al. Metabolic fate and elimination in milk, urine and bile of deoxynivalenol following administration to lactating sheep. , 1987, Journal of environmental science and health. Part. B, Pesticides, food contaminants, and agricultural wastes.
[47] Y. Ueno. Mode of action of trichothecenes , 1977, Annales de la nutrition et de l'alimentation.